Literature DB >> 4050822

Silent myocardial ischemia: classification, prevalence, and prognosis.

P F Cohn.   

Abstract

In the United States there may be four to five million patients with silent myocardial ischemia, including approximately 50,000 asymptomatic patients who have had myocardial infarction, one to two million asymptomatic patients with no history of myocardial infarction or angina, and three million patients with angina. The prognosis for patients who have had infarction and for patients with angina varies, but, in general, it is worse for patients with more extensive disease because sudden cardiac death may be the only clinical sign in asymptomatic patients. Silent myocardial ischemia is an important public health issue; it is hoped that its detection may prevent many episodes of sudden cardiac death annually.

Entities:  

Mesh:

Year:  1985        PMID: 4050822     DOI: 10.1016/0002-9343(85)90486-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Evaluation of exercise electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients.

Authors:  M J Koistinen; H V Huikuri; H Pirttiaho; M K Linnaluoto; J T Takkunen
Journal:  Br Heart J       Date:  1990-01

2.  Influence of post-exercise activity on plasma catecholamines, blood pressure and heart rate in normal subjects.

Authors:  L P Krock; G H Hartung
Journal:  Clin Auton Res       Date:  1992-04       Impact factor: 4.435

3.  Ambulatory 24-h ECG monitoring and cardiovascular autonomic assessment for the screening of silent myocardial ischemia in elderly type 2 diabetic hypertensive patients.

Authors:  Daniele Bosone; Roberto Fogari; Matteo Cotta Ramusino; Natascia Ghiotto; Elena Guaschino; Annalisa Zoppi; Angela D'Angelo; Alfredo Costa
Journal:  Heart Vessels       Date:  2016-10-06       Impact factor: 2.037

Review 4.  Clinical relevance of myocardial "stunning".

Authors:  R Bolli; C J Hartley; R S Rabinovitz
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 5.  Left ventricular function and prognosis after myocardial infarction: rationale for therapeutic strategies.

Authors:  R Scognamiglio; G Fasoli; S Nistri; M Marin; S Dalla Volta
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

6.  Pathophysiology and time course of silent myocardial ischaemia during mental stress: clinical, anatomical, and physiological correlates.

Authors:  S E Legault; M R Freeman; A Langer; P W Armstrong
Journal:  Br Heart J       Date:  1995-03

7.  Identification of a high risk subgroup of patients with silent ischaemia after myocardial infarction: a group for early therapeutic revascularisation?

Authors:  M de Belder; D Skehan; C Pumphrey; B Khan; S Evans; M Rothman; P Mills
Journal:  Br Heart J       Date:  1990-03

8.  Silent myocardial ischemia: Current perspectives and future directions.

Authors:  Amany H Ahmed; Kj Shankar; Hossein Eftekhari; Ms Munir; Jillian Robertson; Alan Brewer; Igor V Stupin; S Ward Casscells
Journal:  Exp Clin Cardiol       Date:  2007

9.  Radial Pulse Spectrum Analysis as Risk Markers to Improve the Risk Stratification of Silent Myocardial Ischemia in Type 2 Diabetic Patients.

Authors:  Chi-Wei Chang; Kuo-Meng Liao; Ying-Chun Chen; Sheng-Hung Wang; Ming-Yie Jan; Gin-Chung Wang
Journal:  IEEE J Transl Eng Health Med       Date:  2018-09-20       Impact factor: 3.316

10.  Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function. A pathophysiological basis for chronic myocardial "stunning".

Authors:  R Bolli; M Zughaib; X Y Li; X L Tang; J Z Sun; J F Triana; P B McCay
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.